openPR Logo
Press release

Nimodipine Market to Witness Robust Expansion by 2029

10-14-2023 07:50 AM CET | Health & Medicine

Press release from: Orion Market Research

Nimodipine Market, a calcium channel blocker initially manufactured and marketed for the treatment of hypertension, is also used in preventing vasospasm secondary to subarachnoid hemorrhage (a type of cerebral hemorrhage). Nimodipine comes under the brand called Nimotop. The global Nimodipine market is expected to grow at a CAGR of xx% during the forecast period.

The prominent Nimodipine market players operating globally include Bionpharma, Sun Pharm Inds, Sofgen pharms, Arbor Pharms, Bayer Vital GmBH and heritage Pharms. Additionally, market drivers associated with the growth of Global Nimodipine market are basically, price analysis, consumption, import/ export analysis, market estimates, raw material costs, location and quantity of product and up & down value chain analysis. Another market driver contributing to the growth of Nimodipine market includes gradual rise in the cases of cerebral hemorrhage and high blood pressure. With the increasing cases of such conditions, the demand for Nimodipine drug is anticipated to increase. 

Geographically the region covered by the market across the globe include Europe (UK, Italy, France, Turkey, Germany and Russia), Middle East and Africa (Egypt, Nigeria, Saudi Arabia, South Africa and UAE), North America (Mexico, United States and Germany), South America (Columbia, Argentina etc).    

Marketing strategies followed by the global market players include value chain analysis and opportunity analysis. They analyze internal firm activities that add values to the product and to the market concerning cost and advantage. On the other hand, opportunities analysis mainly focuses on potential opportunity, strength and weakness for internal and external growth.  

To Request a Sample of our Report on Nimodipine Market:  https://www.omrglobal.com/request-sample/nimodipine-market

Market Coverage

The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030
Segment Covered- 
By Type
By Application
Competitive Landscape- Sun Pharm Inds, Heritage Pharms,  Bionpharma, Arbor Pharms, Thepharmanetwork, Sofgen Pharms and Bayer Vital GmbH

Nimodipine Market Report Segment

By Type

Capsule
Solution
Tablets

By Application

Hospital
Pharmacy
Clinics 

A full Report of Nimodipine Market is Available at:  https://www.omrglobal.com/industry-reports/nimodipine-market

Nimodipine Market Report Segment by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/nimodipine-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nimodipine Market to Witness Robust Expansion by 2029 here

News-ID: 3249755 • Views:

More Releases from Orion Market Research

Mobile Gamma Cameras Market Size, Shares, Business Growth and Upcoming Trends Forecast by 2033
Mobile Gamma Cameras Market Size, Shares, Business Growth and Upcoming Trends Fo …
In 2024, the global Mobile Gamma Cameras Market was valued at approximately USD 57.8 million, and it is expected to reach USD 79.2 million by 2033, reflecting a compound annual growth rate (CAGR) of around 3.39% between 2025 and 2033. Mobile Gamma Cameras Market Overview The Mobile Gamma Cameras Market is seeing steady growth, with demand rising across oncology, cardiology, and nuclear medicine due to its ability to provide portable,
Dental Implants Market Set to Witness Significant Growth by 2033 | Nobel Biocare Services AG, Osstem Implant, BioHorizons, MIS Implants Technologies
Dental Implants Market Set to Witness Significant Growth by 2033 | Nobel Biocare …
In 2024, the global Dental Implants Market was valued at approximately USD 6.8 billion, and it is projected to reach USD 9.8 billion by 2033, representing a compound annual growth rate (CAGR) of around 4.2% from 2025 to 2033. Dental Implants Market Overview The Dental Implants Market is experiencing robust growth driven by rising global incidences of tooth loss, heightened demand for aesthetic and permanent dental solutions, and rapid technological advancements-such
Cell-based Assays Market Set to Witness Significant Growth by 2033 | Becton, Dickinson and Company (BD), PerkinElmer Inc., Merck KGaA
Cell-based Assays Market Set to Witness Significant Growth by 2033 | Becton, Dic …
In 2024, the global Cell-based Assays Market is estimated at approximately USD 24.1 billion, and it is forecast to reach USD 45.2 billion by 2033, reflecting a compound annual growth rate (CAGR) of around 6.9% from 2025 to 2033. Cell-based Assays Market Overview The Cell-based Assays Market is witnessing sustained growth driven by increased demand from drug discovery, disease modeling, and safety/toxicity testing. These assays-crucial in early-stage pharmaceutical R&D-offer biologically relevant
Business Analytics Market Set to Witness Significant Growth by 2030 | Salesforce, Qlik Technologies, MicroStrategy Incorporated
Business Analytics Market Set to Witness Significant Growth by 2030 | Salesforce …
In 2024, the global Business Analytics Market was valued at approximately USD 96.6 billion, and it is anticipated to expand to USD 196.5 billion by 2033, corresponding to a compound annual growth rate (CAGR) of around 7.8% between 2025 and 2033. Business Analytics Market Overview The Business Analytics Market is witnessing robust growth, driven by the proliferation of digital data and rising demand for real-time insights across sectors such as retail, healthcare,

All 5 Releases


More Releases for Nimodipine

Nimodipine Sustained Release Tablets Market Set for Exceptional Growth from 2024 …
The Nimodipine Sustained Release Tablets Market 2024-2023 report provides a comprehensive analysis of Types (30mg/Piece, 60mg/Piece, Others), Application (Hospital, Pharmacy, Others), Analysis of Industry Trends, Growth, and Opportunities, R&D landscape, Data security and privacy concerns Risk Analysis, Pipeline Products, Assumptions, Research Timelines, Secondary Research and Primary Research, Key Insights from Industry Experts, Regional Outlook and Forecast, 2024-2032. Major Players of Nimodipine Sustained Release Tablets Market are: Bionpharma, Arbor Pharmaceuticals, Sofgen Pharmaceuticals, Pharmaceutics International,
Nimodipine Market Size, Share, Growth, Trends, Analysis and Forecast - 2031
Nimodipine, a calcium channel blocker initially manufactured and marketed for the treatment of hypertension, is also used in preventing vasospasm secondary to subarachnoid hemorrhage (a type of cerebral hemorrhage). Nimodipine comes under the brand called Nimotop. The global Nimodipine market is expected to grow at a CAGR of during the forecast period 2024-2031. Get Free Sample link @ https://www.omrglobal.com/request-sample/nimodipine-market The prominent Nimodipine market players operating globally include Bionpharma, Sun Pharm Inds, Sofgen
Nimodipine Market Insights: Demand, Opportunities, and Competitive Landscape
Allied Market Research Analyst have added a new research study on Title Nimodipine Market, Global Outlook and Forecast 2023-2030 with detailed information & Key Players Such as Sofgen Pharmaceuticals, Heritage Pharma Labs, Sun Pharmaceutical, ThePharmaNetwork, Bayer Vital, Arbor Pharmaceuticals, LUSOCHIMICA, Shandong Xinhua, Bionpharma, Omicron Pharma. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes, cost structures, development policies and plans. The facts and data are well
Nimodipine Market Aims to Expand at Double-Digit Growth Rate | Sofgen Pharms, He …
This Nimodipine market research performs systematic analysis of the market to provide profound perceptions, determine market situation and potent advancements and track prior market performances. There were several industries got shutdown due to the COVID-19 plague. This market report captures the considerable losses that businesses got and even guides them how to come out of this pandemic situation. As this pandemic left several adverse effects on different business sectors,
Nimodipine Market is Booming Worldwide (2020-2026)-Says QYResearch | , Sun Pharm …
LOS ANGELES, United States: QY Research has recently published a research report titled, “Global Nimodipine Market Research Report 2020". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Nimodipine market. Players can use the accurate market facts and figures and statistical
Nimodipine Market: Industry Research, Growth, Trends, Analysis & Developments by …
Nimodipine is used to reduce problems due to a specific type of bleeding in the brain. The body responds typically to bleeding by narrowing the blood vessel to slow blood flow. Nimodipine is known as a calcium channel blocker. Nimodipine comes as a capsule and an oral solution (liquid) to take by mouth or be given through a feeding tube. The nimodipine market is developing that wraps details of provincial trade